Network Bio Q1 2023 Investor Update - by network.bio
Network Bio is a horizontal platform generating multi-Omic data across indications — we partner with health systems to build a family of disease-specific tissue biobanks linked to continuous EHR
Network Bio Q1 2023 Investor Update Network Bio is a horizontal platform generating multi-Omic data across indications — we partner with health systems to build a family of disease-specific tissue biobanks linked to continuous EHR network.bio Apr 12, 2023 Share I. Network’s 2023 objective Enter legal relationships with sufficient health systems to collectively provide us a top-of-the-funnel 4,000,000 unique patient encounters per year. This enables us to run studies of choice across multiple indications simultaneously. Raise a priced-round wherein we will pilot this concept with our Network of
saved by
related reading
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- Big Ideas in Tech for 2023: An a16z Omnibus | Andreessen Horowitza16z.com
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- Neion Bioneionbio.com
- Multiply Labs | Robotic Biomanufacturing Infrastructuremultiplylabs.com
- On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Hey Tech, It's Time To Build. In Healthcare. | Andreessen Horowitza16z.com
- Building the Foundation of the Bioeconomy: Biological Data as Critical Infrastructure – KC BioHubkcbiohub.org
- List of Biotechnology Companies to Watch – AI Expanded Versionsubstack.com
- Curie.Biocurie.bio
- Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com